Premium
Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase
Author(s) -
Clay Matthew R.,
Tabor Mark,
Owen John Henry,
Carey Thomas E.,
Bradford Carol R.,
Wolf Gregory T.,
Wicha Max S.,
Prince Mark E.
Publication year - 2010
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.21315
Subject(s) - aldehyde dehydrogenase , cd44 , cancer stem cell , head and neck squamous cell carcinoma , cancer research , cancer cell , stem cell marker , cell , cancer , stem cell , biology , head and neck cancer , pathology , chemistry , medicine , enzyme , biochemistry , microbiology and biotechnology , genetics
Background In accord with the cancer stem cell (CSC) theory, only a small subset of cancer cells are capable of forming tumors. We previously reported that CD44 isolates tumorigenic cells from head and neck squamous cell cancer (HNSCC). Recent studies indicate that aldehyde dehydrogenase (ALDH) activity may represent a more specific marker of CSCs. Methods Six primary HNSCCs were collected. Cells with high and low ALDH activity (ALDH high /ALDH low ) were isolated. ALDH high and ALDH low populations were implanted into NOD/SCID mice and monitored for tumor development. Results ALDH high cells represented a small percentage of the tumor cells (1% to 7.8%). ALDH high cells formed tumors from as few as 500 cells in 24/45 implantations, whereas only 3/37 implantations of ALDH low cells formed tumors. Conclusions ALDH high cells comprise a subpopulation cells in HNSCCs that are tumorigenic and capable of producing tumors at very low numbers. This finding indicates that ALDH activity on its own is a highly selective marker for CSCs in HNSCC. © 2010 Wiley Periodicals, Inc. Head Neck, 2010